CADTH Canadian Drug Expert Committee recommendation: Teduglutide (Revestive -- Shire Pharmaceuticals Ireland Limited) indication: treatment of adults and pediatric patients 1 year of age and above with short bowel syndrome who are dependent on parenteral support
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
CADTH
November 2019, 2019
|
| Edition: | Version 1.0 |
| Series: | CADTH common drug review
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Physical Description: | 1 PDF file (9 pages) |
|---|